サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1496762

臨床試験用品市場：フェーズ、タイプ、製品、治療分野、エンドユーザー別-2024-2030年の世界予測

Clinical Trial Supplies Market by Phase (Phase I, Phase II, Phase III), Type (Biologic Drugs, Medical Devices, Small-Molecules), Product, Therapeutic Area, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 199 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=153.16円
臨床試験用品市場：フェーズ、タイプ、製品、治療分野、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 199 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

臨床試験用品市場規模は、2023年に33億5,000万米ドルと推計され、2024年には36億4,000万米ドルに達し、CAGR 8.43%で2030年には59億2,000万米ドルに達すると予測されています。

調査は、臨床研究の基本的かつ複雑な要素であり、最終的には治療法のブレークスルーを成功させ、患者の治療経路を画期的に改善する道を開くのに役立っています。これらの供給品は、前臨床試験から市販後調査までの様々な研究フェーズに対応し、臨床試験のシームレスな管理と実施を促進します。感染症や慢性疾患の世界の流行と、それに伴う製薬・バイオ医薬品業界の研究開発費を伴う臨床試験の増加は、市場の成長を刺激します。臨床試験用品に関連する高コスト、供給に関する厳しい規制、国境を越えたロジスティクスの課題は、市場の成長を制限します。医薬品開発への重点化と患者中心の臨床試験へのシフトは、臨床試験患者の募集、試験登録、参加者維持の改善につながる可能性があります。加えて、多様なテーマ_KEYWORDにおける継続的な進歩は、製薬・バイオ医薬品企業にとって新たな研究の道を開くものと期待されます。

主な市場の統計
基準年[2023］ 33億5,000万米ドル
予測年［2024] 36億4,000万米ドル
予測年 [2030] 59億2,000万米ドル
CAGR（%） 8.43%

地域別インサイト

米国とカナダを中心とする南北アメリカでは、慢性疾患の診断率が高く、ヘルスケアインフラがしっかりしているため、臨床試験用品への依存度が高いです。過去1年間に登録された主な特許は、サプライチェーンモデルの最適化と、試験供給と需要を一致させるための高度なアナリティクスの採用に関連するものでした。欧州連合（EU）、中東・アフリカでは、ヘルスケアへのアクセスや支出に格差があるため、多様なニーズが見られます。欧州では、研究開発への重点的な投資と高齢者人口の急増に後押しされ、テーマ_KEYWORDに対する需要が安定しています。対照的に、中東やアフリカ諸国は新興市場であり、研究活動は活発であるが、資金やインフラが限られているため伸び悩んでいます。中国、日本、インドを含むアジア太平洋地域は、医療インフラ整備への多額の投資により、高い疾患罹患率が報告されています。製薬業界の活況がこれらの地域の臨床試験用品市場を牽引しており、その需要はスピードよりも費用対効果に左右されます。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、臨床試験用品市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、事業戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、臨床試験用品市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、臨床試験用品市場における現在の立ち位置を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で感染症や慢性疾患の蔓延が増加
      • 製薬・バイオ医薬品業界における研究開発費の増加
    • 抑制要因
      • 臨床試験用品のコストが高い
    • 機会
      • 医薬品開発の重視と患者中心の臨床試験への移行
      • 多様な臨床試験用品の継続的な進歩
    • 課題
      • 臨床試験用品の厳格な規制
  • 市場セグメンテーション分析
    • フェーズ：臨床試験に関する最適な意思決定のために、フェーズごとに臨床試験用品の需要が高まっています。
    • タイプ：慢性疾患に対する画期的な治療法による生物学的医薬品の需要の急増
    • 製品：補助医薬品は、安全性と調査全体の効率性を確保する上で重要なため、臨床試験の重要な要素です。
    • 治療領域：世界中で感染症の負担が増大し、臨床試験用品の需要が高まっています
    • エンドユーザー：R&D活動のアウトソーシングの増加により、CROにおける臨床試験用品の使用が増加しています。
  • 市場動向分析
    • 大手製薬会社は臨床試験数の増加を重視しており、南北アメリカにおける臨床試験用品の必要性が高まっています。
    • アジア太平洋地域における臨床試験能力を強化するための政府の取り組みを拡大し、それを支援する規制や基準を整備する
    • EMEAにおける臨床試験の増加と強力で先進的な製薬業界
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制枠組みの分析

第6章 臨床試験用品市場フェーズ別

  • フェーズI
  • フェーズII
  • フェーズIII
  • フェーズIV

第7章 臨床試験用品市場：タイプ別

  • 生物学的製剤
  • 医療機器
  • 小分子

第8章 臨床試験用品市場：製品別

  • 補助医薬品
  • インタラクティブレスポンステクノロジー（IRT）ソリューション
  • 実験用品
  • 医療機器および診断
  • 薬局用品
  • 調査資料
  • 安全装置

第9章 臨床試験用品市場治療領域別

  • 心臓病学
  • 遺伝性疾患
  • 免疫学
  • 感染症
  • 代謝障害
  • 神経学
  • 腫瘍学

第10章 臨床試験用品市場：エンドユーザー別

  • 契約調査機関
  • 製薬・バイオテクノロジー企業

第11章 南北アメリカの臨床試験用品市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第12章 アジア太平洋地域の臨床試験用品市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第13章 欧州・中東・アフリカの臨床試験用品市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第14章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • シグナル：英国の臨床調査プロバイダー、エルゴメッドが8億8,800万米ドルで買収される
    • サーモフィッシャーサイエンティフィック、新しいスマート冷蔵庫シリーズを発売
    • LoftwareとTenthpinが臨床供給ラベル作成で協力
    • SiteroがClarioのeClinicalテクノロジースイートを買収し、臨床試験の実施を強化
    • レプリミューン社と洞察社、皮膚扁平上皮がん患者を対象にRP1とINCB99280を評価する臨床試験協力および供給契約を締結
    • BD、臨床フローサイトメトリーを自動化する新しいロボットシステムを発表
    • ロンザ、シナフィックスを買収し抗体薬物複合体の提供を強化
    • IDEAYAは、転移性ぶどう膜黒色腫の第一選択治療におけるDarovasertibとCrizotinibの併用を評価する登録試験をサポートするため、ファイザーとの臨床試験協力および供給契約を拡大しました。
    • プラス・セラピューティクス、ピラマル・ファーマ・ソリューションズとの提携を拡大し、進行中および計画中の臨床試験における治験薬需要の増加に対応
    • シーメンスヘルシナーズ、ソーズに実験機器研究開発センターを開設
    • エクスペリック、1,400万米ドルのシリーズB資金調達を完了
    • メドライン、製品の供給力強化のため医療用品在庫に5億米ドルを追加投資

第15章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. CLINICAL TRIAL SUPPLIES MARKET RESEARCH PROCESS
  • FIGURE 2. CLINICAL TRIAL SUPPLIES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CLINICAL TRIAL SUPPLIES MARKET DYNAMICS
  • FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CLINICAL TRIAL SUPPLIES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CLINICAL TRIAL SUPPLIES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE I, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE II, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE III, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE IV, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SMALL-MOLECULES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY AUXILIARY MEDICINAL PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT) SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MICROSCOPES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PIPETTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY MEDICAL DEVICES & DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY BIOHAZARD BAGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COMPOUNDING ASEPTIC ISOLATORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY RESEARCH MATERIALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY SAFETY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY GENETIC DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 82. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 83. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 88. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 89. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 90. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 91. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 92. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 93. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 94. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 95. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 96. AMERICAS CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 97. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 98. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 99. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 104. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 105. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 106. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 107. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 108. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 109. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 110. ARGENTINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 111. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 112. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 113. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 118. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 119. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 120. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 121. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 122. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 123. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. BRAZIL CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 126. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 127. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 132. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 133. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 134. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 135. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 136. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 137. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 138. CANADA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 139. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 140. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 141. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 144. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 145. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 146. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 147. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 148. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 149. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 150. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 151. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 152. MEXICO CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 153. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 154. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 155. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 160. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 161. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 162. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 163. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 164. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 165. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 166. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 167. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 168. UNITED STATES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC CLINICAL TRIAL SUPPLIES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 185. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 186. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 187. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 192. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 193. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 194. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 195. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 196. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 197. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. AUSTRALIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 200. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 201. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 206. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 207. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 208. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 209. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 210. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 211. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 212. CHINA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 213. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 214. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 215. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 220. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 221. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 222. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 223. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 224. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 225. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 226. INDIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 227. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 228. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 229. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 234. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 235. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 236. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 237. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 238. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 239. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. INDONESIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 242. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 243. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 248. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 249. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 250. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 251. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 252. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 253. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 254. JAPAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 255. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 256. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 257. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 258. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 259. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 262. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 263. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 264. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 265. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 266. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 267. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 268. MALAYSIA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 269. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 270. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 271. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 276. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 277. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 278. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 279. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 280. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 281. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. PHILIPPINES CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 284. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 285. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 288. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 289. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 290. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 291. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 292. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 293. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 294. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 295. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 296. SINGAPORE CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 297. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 298. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 299. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 302. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 303. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 304. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 305. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 306. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 307. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 308. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 309. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 310. SOUTH KOREA CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 311. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 312. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 313. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 316. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 317. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 318. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 319. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 320. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 321. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 322. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 323. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 324. TAIWAN CLINICAL TRIAL SUPPLIES MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 325. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2018-2023 (USD MILLION)
  • TABLE 326. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHASE, 2024-2030 (USD MILLION)
  • TABLE 327. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 328. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 329. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 330. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 331. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 332. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY LAB SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 333. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2018-2023 (USD MILLION)
  • TABLE 334. THAILAND CLINICAL TRIAL SUPPLIES MARKET SIZE, BY PHARMACY SUPPLIES, 2024-2030 (USD MILLION)
  • TABLE 335. THAIL
目次
Product Code: MRR-E0619F076721

[199 Pages Report] The Clinical Trial Supplies Market size was estimated at USD 3.35 billion in 2023 and expected to reach USD 3.64 billion in 2024, at a CAGR 8.43% to reach USD 5.92 billion by 2030.

Clinical trial supplies are a fundamental yet complex component of clinical research, ultimately helping pave the way toward successful therapeutic breakthroughs and monumental enhancements in patient care pathways. These supplies cater to various research phases, from pre-clinical examinations to post-marketing surveillance studies, thus facilitating the seamless management and execution of clinical investigations. The increasing prevalence of infectious and chronic diseases worldwide and the subsequent rise in clinical trials with research and development expenditure of the pharmaceutical and biopharmaceutical industry stimulates market growth. The high cost associated with clinical trial supplies, stringent regulations for supplies, and cross-border logistics challenges restrict market growth. Growing emphasis on drug development and shifting towards patient-centric clinical trials offer the potential for better clinical trial patient recruitment, study enrollment, and participant retention. In addition, ongoing advancements in a diverse range of clinical trial supplies are expected to open new research avenues for pharmaceutical and biopharmaceutical companies.

KEY MARKET STATISTICS
Base Year [2023] USD 3.35 billion
Estimated Year [2024] USD 3.64 billion
Forecast Year [2030] USD 5.92 billion
CAGR (%) 8.43%

Regional Insights

In the Americas, primarily the United States and Canada, there is a significant dependence on clinical trial supplies due to a high diagnosis rate of chronic diseases and robust healthcare infrastructure. Over the past year, the major patents registered revolved around optimizing supply chain models and employing advanced analytics to align trial supply with demand. The European Union (EU), the Middle East, and Africa exhibit a diverse range of needs due to discrepancies in healthcare access and spending. Europe witnesses steady demand for clinical trial supplies, fueled by heavy investments in research and development initiatives and a surge in the geriatric population. In contrast, Middle Eastern and African countries encompass emerging markets with rising research activities yet laid back due to limited funding and infrastructural impediments. Asia-Pacific, including China, Japan, and India, reports a high disease prevalence, bridged by substantial investments in improving healthcare infrastructure. The booming pharmaceutical industry drives the clinical trial supplies market in these regions, and the demand is dictated more by cost-efficacy rather than speed, mirroring their unique healthcare economic dynamics.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Clinical Trial Supplies Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing prevalence of infectious and chronic diseases worldwide
      • Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • Market Restraints
      • High cost of clinical trial supplies
    • Market Opportunities
      • Emphasis on drug development and shift towards patient-centric clinical trials
      • Ongoing advancements in a diverse range of clinical trial supplies
    • Market Challenges
      • Stringent regulations for clinical trial supplies
  • Market Segmentation Analysis
    • Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Clinical Trial Supplies Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Clinical Trial Supplies Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal

Permira, a UK private equity firm, agreed to acquire Ergomed for USD 888.1 million. Ergomed is a clinical trial development and management services provider, catering to clients across more than 100 countries. This strategic acquisition can expand Permira's already impressive portfolio of medical companies, including Neurapharm and Cambrex. [Published On: 2023-09-04]

Thermo Fisher Scientific Launches New Smart Refrigerator Series

Thermo Fisher Scientific introduced the Thermo Scientific TM TSG series refrigerators, specifically engineered to cater to the stringent demands of diverse industries. These cutting-edge refrigerators leverage advanced technology to ensure accurate temperature control, effectively preserving the integrity of vaccines and pharmaceuticals. By minimizing temperature fluctuations, these refrigerators effectively mitigate the risks associated with such variations, safeguarding medical products' potency and efficacy. [Published On: 2023-08-16]

Loftware and Tenthpin Collaborate on Clinical Supply Labeling

Loftware and Tenthpin collaborated to launch a software called Loftware Prisym 360, which is specifically designed for clinical supply labeling. The main objective of this partnership is to address the growing challenges faced by clinical trial supply teams within the pharmaceutical industry. This agreement enables both Loftware and Tenthpin to actively promote, educate, and implement a comprehensive content and labeling solution for their clinical customers. [Published On: 2023-08-02]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Clinical Trial Supplies Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Clinical Trial Supplies Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Almac Group Limited, B. Braun SE, Baxter International, Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cardinal Health, Inc., Charles River Laboratories, Inc., COREX LOGISTICS LIMITED, Emsere B.V by Medicapital Holdco B.V., Eppendorf SE, Evident Corporation by Olympus Corporation, F. Hoffmann-La Roche Ltd., Fujifilm Group, Hipro Biotechnology Co., Ltd., Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Immudex ApS, Incyte Corporation, IQVIA Inc., Johnson & Johnson Services, Inc., KLIFO A/S, Labnet International, Leica Microsystems GmbH by Danaher Corporation, llumina, Inc., Lonza Group Ltd., Medline Industries, LP, Merck KGaA, Myonex, LLC, Novo Nordisk A/S, Nuvisan GmbH, Parexel International Corporation, Perceptive Informatics LLC and its affiliates, d/b/a Calyx, PerkinElmer Inc. by Revvity, Inc., Pfizer Inc., Promega Corporation, Recipharm AB, Rubicon Research Pvt. Ltd., Sekisui Diagnostics Group, Sharp Services, LLC, Siemens Healthcare GmbH, Smith & Nephew PLC, Stryker Corporation, Thermo Fisher Scientific Inc., and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Clinical Trial Supplies Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Type
    • Biologic Drugs
    • Medical Devices
    • Small-Molecules
  • Product
    • Auxiliary Medicinal Products
    • Interactive Response Technology (IRT) solutions
    • Lab Supplies
      • Centrifuges
      • Microscopes
      • Pipettes
      • Reagents
    • Medical Devices & Diagnostics
    • Pharmacy Supplies
      • Biohazard Bags
      • Compounding Aseptic Isolators
      • Sterilization Equipment
    • Research Materials
    • Safety Equipment
  • Therapeutic Area
    • Cardiology
    • Genetic Diseases
    • Immunology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Oncology
  • End User
    • Contract Research Organisations
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of infectious and chronic diseases worldwide
      • 5.1.1.2. Rising research and development expenditure by pharmaceutical and biopharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of clinical trial supplies
    • 5.1.3. Opportunities
      • 5.1.3.1. Emphasis on drug development and shift towards patient-centric clinical trials
      • 5.1.3.2. Ongoing advancements in a diverse range of clinical trial supplies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations for clinical trial supplies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Phase: Growing demand for clinical trial supplies for each phase for optimal decision-making regarding clinical trial
    • 5.2.2. Type: Surge in biologic drugs demand with breakthrough therapies for chronic ailments
    • 5.2.3. Product: Auxiliary medicinal products are vital elements of clinical trials, owing to their significance of assuring safety, and efficiency in the overall research operation
    • 5.2.4. Therapeutic Area: Rising burden of infectious diseases worldwide create a demand for clinical trial supplies
    • 5.2.5. End User: Growing use of clinical trial supplies in CROs due to rising outsourcing of R&D activities
  • 5.3. Market Trend Analysis
    • 5.3.1. Well-established pharmaceutical companies emphasis on increasing the number of clinical trials, propelling the need for clinical trial supplies in the Americas
    • 5.3.2. Expanding government initiatives to strengthen the clinical trial capabilities coupled with supportive regulations and standards in the APAC region
    • 5.3.3. Increasing number of clinical trials and strong and advanced pharmaceutical sector in the EMEA
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Clinical Trial Supplies Market, by Phase

  • 6.1. Introduction
  • 6.2. Phase I
  • 6.3. Phase II
  • 6.4. Phase III
  • 6.5. Phase IV

7. Clinical Trial Supplies Market, by Type

  • 7.1. Introduction
  • 7.2. Biologic Drugs
  • 7.3. Medical Devices
  • 7.4. Small-Molecules

8. Clinical Trial Supplies Market, by Product

  • 8.1. Introduction
  • 8.2. Auxiliary Medicinal Products
  • 8.3. Interactive Response Technology (IRT) solutions
  • 8.4. Lab Supplies
  • 8.5. Medical Devices & Diagnostics
  • 8.6. Pharmacy Supplies
  • 8.7. Research Materials
  • 8.8. Safety Equipment

9. Clinical Trial Supplies Market, by Therapeutic Area

  • 9.1. Introduction
  • 9.2. Cardiology
  • 9.3. Genetic Diseases
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Metabolic Disorders
  • 9.7. Neurology
  • 9.8. Oncology

10. Clinical Trial Supplies Market, by End User

  • 10.1. Introduction
  • 10.2. Contract Research Organisations
  • 10.3. Pharmaceutical & Biotechnology Companies

11. Americas Clinical Trial Supplies Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Clinical Trial Supplies Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Clinical Trial Supplies Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Signal: UK Clinical Research Provider Ergomed Bought Out in USD 888 Million Deal
    • 14.3.2. Thermo Fisher Scientific Launches New Smart Refrigerator Series
    • 14.3.3. Loftware and Tenthpin Collaborate on Clinical Supply Labeling
    • 14.3.4. Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery
    • 14.3.5. Replimune and Incyte Enter into Clinical Trial Collaboration and Supply Agreement to Evaluate RP1 and INCB99280 in Patients with Cutaneous Squamous Cell Carcinoma
    • 14.3.6. BD Launches New Robotic System to Automate Clinical Flow Cytometry
    • 14.3.7. Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering
    • 14.3.8. IDEAYA Expands Clinical Trial Collaboration and Supply Agreements with Pfizer to Support Registrational Trial Evaluating Darovasertib and Crizotinib Combination in First-Line Metastatic Uveal Melanoma
    • 14.3.9. Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions to Meet Increase in Investigational Drug Demand for Ongoing and Planned Clinical Trials
    • 14.3.10. Siemens Healthineers Launch Laboratory Equipment R&D Centre in Swords
    • 14.3.11. Experic Closes USD 14 Million Series B Financing
    • 14.3.12. Medline Invests Additional USD 500M in Medical Supply Inventory to Boost Product Availability

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio